Journal of the European Academy of Dermatology & Venereology

Classification and design of teledermatology practice: What dermatoses? Which technology to apply?
pp. 865-875(11)
Author: Kanthraj, GR

Current topical and systemic approaches to treatment of rosacea
pp. 876-882(7)
Authors: Korting, HC; Schöllmann, C

Effect of hair removal by Nd:YAG laser on the recurrence of pilonidal sinus
pp. 883-886(4)
Authors: Badawy, EA; Kanawati, MN

A new method for facial epidermoid cyst removal with minimal incision
pp. 887-890(4)
Authors: Yang, H-J; Yang, K-C

Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: a comparative pilot study
pp. 891-895(5)
Authors: Fernández-Guarino, M; Harto, A; Sánchez-Ronco, M; García-Morales, I; Jaén, P

Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis
pp. 896-904(9)
Authors: Luger, TA; Barker, J; Lambert, J; Yang, S; Robertson, D; Foehl, J; Molta, CT; Boggs, R

Mometasone furoate 0.1% and salicylic acid 5% vs. mometasone furoate 0.1% as sequential local therapy in psoriasis vulgaris
pp. 905-912(8)
Authors: Tiplica, G-S; Salavastru, CM

Isomorphic cutaneous graft-versus-host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo-transplanted patients
pp. 913-918(6)
Authors: Vassallo, C; Brazzelli, V; Zecca, M; Locatelli, F; Alessandrino, PE; Borroni, G

Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial
pp. 919-926(8)
Authors: Ortonne, JP; Ganslandt, C; Tan, J; Nordin, P; Kragballe, K; Segaert, S

Knowledge and attitude regarding human immunodeficiency virus/acquired immunodeficiency syndrome in dermatological outpatients
pp. 927-933(7)
Authors: Kouznetsov, L; Kuznetsov, AV; Ruzicka, T; Matterne, U; Wienecke, R; Zippel, SA

The hair follicle melanocytes in vitiligo in relation to disease duration
pp. 934-939(6)
Authors: Anbar, T S; Abdel-Raouf, H; Awad, S S; Ragaie, M H; Abdel-Rahman, A T

Skin hydration and transepidermal water loss in patients with a history of sulfur mustard contact: a case-control study
pp. 940-944(5)
Authors: Davoudi, Seyyed Masoud; Keshavarz, Saeed; Sadr, Bardia; Shohrati, Majid; Naghizadeh, Mohammad Mehdi; Farsinejad, Khalil; Rashighi-Firouzabadi, Mehdi; Zartab, Hamed; Firooz, Alireza

Psycho-cutaneous disorders: an epidemiologic study
pp. 945-947(3)
Authors: Ehsani, AH; Toosi, S; Shahshahani, M Mirshams; Arbabi, M; Noormohammadpour, P

Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study
pp. 948-950(3)
Authors: Malekzad, F; Arbabi, M; Mohtasham, N; Toosi, P; Jaberian, M; Mohajer, M; Mohammadi, MR; Roodsari, MR; Nasiri, S

Response of vitiligo to once- vs. twice-daily topical tacrolimus: a controlled prospective, randomized, observer-blinded trial
pp. 951-953(3)
Authors: Radakovic, S; Breier-Maly, J; Konschitzky, R; Kittler, H; Sator, P; Hoenigsmann, H; Tanew, A

Angiolymphoid hyperplasia with eosinophilia of the scalp: promising results of long-pulsed tunable dye laser treatment
pp. 954-955(2)
Authors: Vanhooteghem, O; Flagothier, C; de la Brassinne, M

Botulinum toxin for inverse psoriasis?
pp. 955-955(1)
Authors: Chroni, E; Monastirli, A; Tsambaos, D

Botulinum toxin type A for the treatment of inverse psoriasis
pp. 955-956(2)
Authors: Zanchi, M; Favot, F; Bizzarini, M

Autologous serum skin test: is the paradigm falling?
pp. 956-957(2)
Authors: Taskapan, O; Kutlu, A

Improvement of psoriasis after antibiotic therapy with cefuroxime axetil
pp. 957-958(2)
Authors: Walecka, I; Olszewska, M; Rakowska, A; Slowinska, M; Sicinska, J; Piekarczyk, E; Kowalska-Oledzka, E; Goralska, B; Rudnicka, L

Pemphigus and drug addiction
pp. 958-958(1)
Authors: Puca, RV; Ruocco, E; Lo Schiavo, A

Sensitivity of autologous serum skin test for chronic autoimmune urticaria
pp. 958-959(2)
Authors: Zauli, D; Giorgi, GD; Tovoli, F

Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect
pp. 959-960(2)
Authors: Lopez, V; Pinazo, I; Marti, N; Monteagudo, C; Jorda, E

Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy
pp. 960-962(3)
Authors: Kim, MJ; Kim, JS; Cho, SB

Coexistence of paraneoplastic pemphigus and bullous pemphigoid
pp. 962-964(3)
Authors: Kakurai, M; Demitsu, T; Iida, E; Umemoto, N; Yamada, T; Yoneda, K; Kako, S; Ohshima, K; Ohyama, B; Hashimoto, T

An old woman with painful oral intake
pp. 964-965(2)
Authors: Herrero-González, JE; Parera, E; Viñas, L; Pujol, RM

A case of solid facial oedema successfully treated with isotretinoin
pp. 965-966(2)
Authors: Manolache, L; Benea, V; Petrescu-Seceleanu, D

Cutaneous T-cell lymphoma following treatment of rheumatoid arthritis with tumour necrosis factor-α blocking agents: two cases
pp. 967-968(2)
Authors: Lourari, S; Prey, S; Livideanu, C; Jamard, B; Lamant, L; Cantagrel, A; Paul, C

Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept
pp. 968-969(2)
Authors: Moustou, AE; Stratigos, AJ; Vergou, T; Gregoriou, S; Georgala, S; Danopoulou, I

A rapidly changing scar 18 months after melanoma excision
pp. 969-971(3)
Authors: Meiss, F; Technau, K; Nashan, D

Successful association in the treatment of pityriasis lichenoides et varioliformis acuta
pp. 971-972(2)
Authors: Di Costanzo, L; Balato, N; La Bella, S; Balato, A

Perforating dermatosis in a patient receiving bevacizumab
pp. 972-974(3)
Authors: Vano-Galvan, S; Moreno, C; Medina, J; Pérez-García, B; García-López, JL; Jaén, P

Doripenem-induced intertriginous drug eruption as a mild form of AGEP
pp. 974-976(3)
Authors: Sawada, Yu; Sugita, Kazunari; Fukamachi, Shoko; Bito, Toshinori; Nakamura, Motonobu; Tokura, Yoshiki

Adolescent plaque psoriasis: Our experience using etanercept
pp. 976-977(2)
Authors: Ruiz-Villaverde, R; Sánchez-Cano, D; Abalos-Medina, G

Keratosis follicularis and dermatomyositis: Is there a common pathogenesis?
pp. 977-978(2)
Authors: Lee, WJ; Park, GH; Lee, MW; Choi, JH; Moon, KC; Koh, JK

Topical treatment of bowenoid papulosis of the penis with imiquimod
pp. 978-979(2)
Authors: Matuszewski, M; Michajłowski, I; Michajłowski, J; Sokołowska-Wojdyło, M; Włodarczyk, A; Krajka, K

Etanercept in severe, recalcitrant psoriasis: clinical response, safety profile and predictors of response based on a single institution's experience
pp. 979-982(4)
Authors: Antoniou, C; Dessinioti, C; Stratigos, A; Avgerinou, G; Stavropoulos, P; Katsambas, A

ANNOUNCEMENTS
pp. 983-983(1)

FORTHCOMING EVENTS
pp. 984-984(1)